Sort
172,184 grants matching “inflammation”
Host and viral genomic determinants of HIV latent reservoir size and characteristics in individuals with substance use disorders
$950,298Robert F Siliciano · Johns Hopkins University · R61 · FY2018 · DA
Genetic &Clinical Risk for Human SLE Nephritis
$950,223Ohio State University · P01 · FY2004 · DK
HBI-002 to Treat Diabetic Retinopathy
$950,200Edward Gomperts · Hillhurst Biopharmaceuticals, Inc. · R44 · FY2024 · EY
Intracellular Signaling In Endocrine Cells
$950,172Stanko S. Stojilkovic · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2021 · HD
Research training in respiratory biology
$950,124Gokhan M. Mutlu · University Of Chicago · T32 · FY2024 · HL
Analysis of Human Genome Using Integrated Technologies
$950,047Michael P Snyder · Yale University · P50 · FY2009 · HG
UVA Asthma and Allergic Diseases Center
$950,019University Of Virginia Charlottesville · P01 · FY2002 · AI
Molecular Mechanisms Of Glaucoma
$949,683Stanislav I Tomarev · National Eye Institute · ZIA · FY2012 · EY
Tissue mechanics reprograms the tissue to malignancy and metastasis
$949,620Valerie Marie Weaver · University Of California, San Francisco · R35 · FY2022 · CA
PORPHYRINS AS MICROBICIDES FOR PREVENTION OF STDS/HIV
$949,462Emory University · P01 · FY2002 · AI
Pathogenesis of Atopic Dermatitis
$949,351Mark H. Kaplan · Indiana Univ-Purdue Univ At Indianapolis · U19 · FY2007 · AI
DEFINING A NOVEL THERAPEUTIC APPLICATION OF LACTOFERRING FOR INTESTINAL INFLAMMATION
$949,216The Regents Of The University Of Colorado · · FY2021 · Defense Health Agency
Prospective Cohort Collaborative in Pancreatic Cancer Epidemiology & Pathogenesis
$949,009Charles S Fuchs · Dana-Farber Cancer Inst · R01 · FY2010 · CA
Anaerobic Manufacturing and Molecular Analytical Process Optimization to Support Clinical Development of Live Biotherapeutic Products
$948,833Ricardo Valladares · Siolta Therapeutics, Inc. · R44 · FY2024 · AI
Substance Use and Immunity in HIV+ Adolescents by Systems Biology
$948,825Maureen M Goodenow · University Of Florida · R01 · FY2010 · DA
CTRIP: Treatment of Sickle Cell Crisis with inhibitors of NKT cell activation
$948,786David G. Nathan · Dana-Farber Cancer Inst · RC2 · FY2010 · HL
BMP Inhibitors to Treat Fibrodysplasia Ossificans Progressiva
$948,663Philip Sanderson · National Center For Advancing Translational Sciences · ZIA · FY2019 · TR
Role Of Ectodysplasin-a In Skin Appendage Formation
$948,474David Schlessinger · National Institute On Aging · ZIA · FY2015 · AG
Macular Edema Treatment Trials Associated with MUST (META-MUST)
$948,462Janet T. Holbrook · Johns Hopkins University · U10 · FY2019 · EY
Translational Research and Evolving Alcoholic hepatitis Treatment (TREAT-IU)
$948,453David W Crabb · Indiana University Indianapolis · U01 · FY2012 · AA
Core G: Patient-Oriented Research Core
$948,439Ronald Gary Tompkins · Massachusetts General Hospital · U54 · FY2009 · GM
Novel Stem Cell Immunotherapy for MDR-Tuberculosis
$948,345Chinnaswamy Jagannath · Methodist Hospital Research Institute · R01 · FY2025 · AI
programmed cell death in regulation of autoimmunity
$948,335Richard M Siegel · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2010 · AR
TL1A and its receptor DR3 in normal and autoimmune T cell responses
$948,335Richard M Siegel · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2010 · AR
Project 3
$948,276Akira Sawa · Johns Hopkins University · P50 · FY2025 · MH